XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Collaborative Agreements (Details 5) (USD $)
3 Months Ended 9 Months Ended 40 Months Ended 1 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Dec. 31, 2011
item
Aug. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Collaborative Agreements disclosures                  
Amount of arrangement consideration included in license and milestone fees $ 5,078,000imgn_LicenseAndMilestoneFees $ 305,000imgn_LicenseAndMilestoneFees $ 52,729,000imgn_LicenseAndMilestoneFees $ 39,150,000imgn_LicenseAndMilestoneFees          
Lilly                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement         28,200,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
       
Lilly | Sales milestones                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement         800,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_SalesMilestonesMember
       
Lilly | Future Technological Improvements                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement         600,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_FutureTechnologicalImprovementsMember
       
Lilly | Research Services                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement         3,300,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_ResearchServicesMember
       
Lilly | Right-to-test agreement                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement           20,000,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
     
Number of development and commercialization licenses taken           3imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
     
Lilly | Right-to-test agreement | No exercise fee                  
Collaborative Agreements disclosures                  
License exercise fee, per subsequent license           0imgn_CollaborativeArrangementExerciseFeePotentialPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_NoExerciseFeeMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
     
Lilly | Right-to-test agreement | Exercise fee of $2 million                  
Collaborative Agreements disclosures                  
License exercise fee, per subsequent license           2,000,000imgn_CollaborativeArrangementExerciseFeePotentialPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_ExerciseFeeMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
     
Lilly | Development and Commercialization License                  
Collaborative Agreements disclosures                  
Payments received under collaboration agreement         23,500,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
       
Estimated utilization period after commercialization     10 years            
Discount rate (as a percent)     16.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
           
Amount of arrangement consideration included in license and milestone fees     15,600,000imgn_LicenseAndMilestoneFees
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
      7,800,000imgn_LicenseAndMilestoneFees
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
   
Estimated term of development and commercialization license     25 years            
Lilly | Development and Commercialization License | No exercise fee | Maximum                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               200,500,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_NoExerciseFeeMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Lilly | Development and Commercialization License | Exercise fee of $2 million                  
Collaborative Agreements disclosures                  
License exercise fee, per subsequent license               2,000,000imgn_CollaborativeArrangementExerciseFeePotentialPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_ExerciseFeeMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
2,000,000imgn_CollaborativeArrangementExerciseFeePotentialPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_ExerciseFeeMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
Lilly | Development and Commercialization License | Exercise fee of $2 million | Maximum                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               199,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_ExerciseFeeMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Lilly | Development and Commercialization License | Development milestones | No exercise fee                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               30,500,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_NoExerciseFeeMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Lilly | Development and Commercialization License | Development milestones | Exercise fee of $2 million                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               29,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_ExerciseFeePerLicenseAxis
= imgn_ExerciseFeeMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Lilly | Development and Commercialization License | Development milestones | Phase I clinical trial                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license 5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIClinicalTrialMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
  5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIClinicalTrialMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
  5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIClinicalTrialMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
       
Lilly | Development and Commercialization License | Regulatory milestones                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               70,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_RegulatoryMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Lilly | Development and Commercialization License | Sales milestones                  
Collaborative Agreements disclosures                  
Potential milestone payments for each subsequent license               $ 100,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_SalesMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Exclusive license | Lilly | Development and Commercialization License                  
Collaborative Agreements disclosures                  
Number of development and commercialization licenses taken     3imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_EliLillyAndCompanyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember